| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1051677189 |
| P356 | DOI | 10.1186/1742-4690-5-40 |
| P8608 | Fatcat ID | release_fgfk4ohyencufafmp6tbelimsq |
| P932 | PMC publication ID | 2412914 |
| P698 | PubMed publication ID | 18498648 |
| P5875 | ResearchGate publication ID | 5329767 |
| P50 | author | Fatah Kashanchi | Q91617579 |
| Kylene Kehn-Hall | Q37837531 | ||
| P2093 | author name string | David E Symer | |
| Rachel Van Duyne | |||
| Zachary Klase | |||
| Weilin Wu | |||
| Caitlin Pedati | |||
| Elizabeth K Flynn | |||
| Rebecca Easley | |||
| Reem Berro | |||
| P2860 | cites work | Protein methylation is required to maintain optimal HIV-1 infectivity | Q21245198 |
| The tripartite motif family identifies cell compartments | Q24291183 | ||
| The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription | Q24307870 | ||
| Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators | Q24309765 | ||
| The histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells | Q24336175 | ||
| In vivo HP1 targeting causes large-scale chromatin condensation and enhanced histone lysine methylation | Q24529080 | ||
| Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription | Q24534441 | ||
| Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation | Q24537588 | ||
| Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression | Q24558697 | ||
| In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor | Q24655901 | ||
| Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region | Q24672150 | ||
| In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP | Q24675459 | ||
| Interaction of human immunodeficiency virus type 1 Tat with a unique site of TFIID inhibits negative cofactor Dr1 and stabilizes the TFIID-TFIIA complex | Q24681921 | ||
| SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins | Q24685694 | ||
| The SET-domain protein superfamily: protein lysine methyltransferases | Q24811144 | ||
| Tat gets the "green" light on transcription initiation | Q24815711 | ||
| Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin | Q25256895 | ||
| Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail | Q27638012 | ||
| Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains | Q27641772 | ||
| Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins | Q27860456 | ||
| Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain | Q27860477 | ||
| Signaling to chromatin through histone modifications | Q28142598 | ||
| Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones | Q28143943 | ||
| A non-proteolytic role for ubiquitin in Tat-mediated transactivation of the HIV-1 promoter | Q28190014 | ||
| Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA | Q28203201 | ||
| Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing nuclear cofactors: a potential mechanism for regulating the switch between coactivation and corepression | Q28208645 | ||
| SNFing HIV transcription | Q38253738 | ||
| Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. | Q41079020 | ||
| TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2. | Q41122096 | ||
| HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element | Q41130969 | ||
| Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency | Q42100247 | ||
| HIV-1 tat transcriptional activity is regulated by acetylation | Q42163503 | ||
| HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors | Q42951883 | ||
| Identification of novel histone post-translational modifications by peptide mass fingerprinting | Q44561152 | ||
| Effects of tethering HP1 to euchromatic regions of the Drosophila genome. | Q52604132 | ||
| Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity | Q63351469 | ||
| Evidence for Functional Interaction between the HIV-1 Tat Transactivator and the TATA Box Binding Proteinin Vivo | Q71871314 | ||
| Antibodies against the folding domain of histone H5 cross-react with H1(0) but not with H1 | Q72673749 | ||
| Direct interaction of human TFIID with the HIV-1 transactivator tat | Q28250314 | ||
| A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA | Q28263974 | ||
| HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors | Q28298100 | ||
| Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes | Q28304889 | ||
| The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18 | Q28509358 | ||
| Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3 | Q28609869 | ||
| Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation | Q29614524 | ||
| Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly | Q29614718 | ||
| Histone and chromatin cross-talk | Q29617179 | ||
| Heterochromatin and epigenetic control of gene expression | Q29618486 | ||
| HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation | Q29620799 | ||
| Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena | Q30304568 | ||
| Specificity of the HP1 chromo domain for the methylated N-terminus of histone H3. | Q30307942 | ||
| HIV-1 Tat protein trans-activates transcription in vitro | Q30411837 | ||
| A real-time view of the TAR:Tat:P-TEFb complex at HIV-1 transcription sites | Q30479706 | ||
| Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32. | Q33236503 | ||
| Multifaceted activities of the HIV-1 transactivator of transcription, Tat. | Q33743566 | ||
| Transcriptional repression of euchromatic genes by Drosophila heterochromatin protein 1 and histone modifiers | Q33944585 | ||
| TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication | Q34030432 | ||
| Re-SET-ting heterochromatin by histone methyltransferases | Q34253201 | ||
| SET domain proteins modulate chromatin domains in eu- and heterochromatin. | Q34458687 | ||
| Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy | Q34714816 | ||
| HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. | Q34985945 | ||
| Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription | Q35040154 | ||
| Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription | Q35131134 | ||
| Nuclear organization and the control of HIV-1 transcription | Q35631972 | ||
| Methylation: a regulator of HIV-1 replication? | Q35633276 | ||
| Chromatin remodeling and modification during HIV-1 Tat-activated transcription | Q35716781 | ||
| Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1. | Q35874904 | ||
| Electroporation of viral transactivator proteins into lymphocyte suspension cells | Q35927699 | ||
| HIV-1 Tat protein promotes formation of more-processive elongation complexes | Q35937536 | ||
| Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex | Q35940053 | ||
| The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation | Q37506941 | ||
| P304 | page(s) | 40 | |
| P577 | publication date | 2008-05-22 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | Lysine methylation of HIV-1 Tat regulates transcriptional activity of the viral LTR. | |
| P478 | volume | 5 |
| Q39443387 | A whole genome screen for HIV restriction factors |
| Q34005293 | Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1). |
| Q37410634 | Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. |
| Q34032827 | BET bromodomain inhibition as a novel strategy for reactivation of HIV-1 |
| Q24307396 | CLLD8/KMT1F is a lysine methyltransferase that is important for chromosome segregation |
| Q33347964 | Cell-type-specific proteome and interactome: using HIV-1 Tat as a test case |
| Q41818257 | Characterization of HIV Tat modifications using novel methyl-lysine-specific antibodies |
| Q37589012 | Chromatin dynamics associated with HIV-1 Tat-activated transcription |
| Q33418619 | Computational identification of protein methylation sites through bi-profile Bayes feature extraction |
| Q37127522 | Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development |
| Q61799358 | Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat |
| Q38557842 | Emerging roles of lysine methylation on non-histone proteins |
| Q33768729 | Epigenetic analysis of HIV-1 proviral genomes from infected individuals: predominance of unmethylated CpG's. |
| Q36398891 | Epigenetic regulation of oogenesis and germ stem cell maintenance by the Drosophila histone methyltransferase Eggless/dSetDB1. |
| Q49956170 | Expression profiling of chromatin-modifying enzymes and global DNA methylation in CD4+ T cells from patients with chronic HIV infection at different HIV control and progression states. |
| Q92135927 | Genetic variation and function of the HIV-1 Tat protein |
| Q54214251 | HIV latency reversing agents act through Tat post translational modifications |
| Q91711649 | HIV-1 Tat Length: Comparative and Functional Considerations |
| Q36412589 | HIV-Tat regulates macrophage gene expression in the context of neuroAIDS. |
| Q45966440 | Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond. |
| Q40333502 | Identification and Analysis of the SET-Domain Family in Silkworm, Bombyx mori |
| Q57315736 | Identification and functional characterization of lysine methyltransferases of Entamoeba histolytica |
| Q21245051 | In vitro nuclear interactome of the HIV-1 Tat protein |
| Q21245111 | Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells |
| Q37970950 | Lysine methylation: beyond histones |
| Q34363381 | Modulation of the stability and activities of HIV-1 Tat by its ubiquitination and carboxyl-terminal region |
| Q37509718 | Molecular and genetic characterization of natural HIV-1 Tat Exon-1 variants from North India and their functional implications |
| Q37644561 | Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies |
| Q35868299 | Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression |
| Q35848560 | New and novel intrinsic host repressive factors against HIV-1: PAF1 complex, HERC5 and others |
| Q27670607 | Novel Histone H3 Binding Protein ORF158L from the Singapore Grouper Iridovirus |
| Q39135199 | Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. |
| Q36601890 | Potential of Radiation-Induced Cellular Stress for Reactivation of Latent HIV-1 and Killing of Infected Cells |
| Q37615671 | SET for life: biochemical activities and biological functions of SET domain-containing proteins |
| Q34208487 | Substrate and product specificities of SET domain methyltransferases |
| Q37941687 | Targets in Epigenetics: Inhibiting the Methyl Writers of the Histone Code |
| Q39777846 | The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. |
| Q37958430 | The control of HIV transcription: keeping RNA polymerase II on track |
| Q35023253 | The effect of N-acetylation and N-methylation of lysine residue of Tat peptide on its interaction with HIV-1 TAR RNA. |
| Q26853164 | The functional diversity of protein lysine methylation |
| Q37825906 | Tits and bits of HIV Tat protein. |
| Q37955164 | Transcriptional Control of HIV Replication by Multiple Modulators and Their Implication for a Novel Antiviral Therapy |
| Q33565167 | Transcriptional Gene Silencing (TGS) via the RNAi Machinery in HIV-1 Infections |
| Q35026881 | Viral-host interactions that control HIV-1 transcriptional elongation |
| Q37220038 | What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? |
| Q33985168 | microRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection |
| Q35641069 | p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation |
| Q36827396 | tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection. |
Search more.